Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan with clopidogrel and/or leflunomide for progressive IgA nephropathy
ChiCTR-TRC-10000776Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telmisartan, clopidogrel and leflunomide in IgA nephropathy (IgAN) (4 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Urine protein. Started Jun 2009; status: completed.
02
Drugs
telmisartanclopidogrelleflunomide
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ChiCTR-TRC-10000776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000776.